A transgene coding for a human insulin analog has a mitogenic effect on murine embryonic beta cells

Area of Science:

• Endocrinology
• Developmental Biology
• Molecular Biology

Background:

• Insulin and its analogs play crucial roles in glucose homeostasis and beta-cell function.
• Mutant forms of insulin can exhibit altered receptor binding affinities and signaling pathways.
• Understanding beta-cell proliferation is vital for addressing diabetes and related metabolic disorders.

Purpose of the Study:

• To investigate the mitogenic effects of specific human insulin mutant forms on pancreatic beta cells.
• To compare the impact of [AspB10]-proinsulin/insulin, [LeuA3]insulin, and a double mutant on beta-cell development and proliferation.
• To determine the specificity of any observed mitogenic effects on embryonic beta cells.

Main Methods:

• Generation of transgenic mice expressing distinct human insulin mutant forms: [AspB10]-proinsulin/insulin ([AspB10]ProIN/IN), [LeuA3]insulin, and a double mutant ([LeuA3, AspB10]insulin).
• Analysis of beta-cell abundance and proliferation rates in embryonic and adult transgenic mice compared to controls.
• Assessment of the proliferation rates in other cell types (glucagon alpha cells, adrenal chromaffin cells) to determine specificity.

Main Results:

• The [AspB10]ProIN/IN analog significantly increased beta-cell abundance (2-fold) and proliferation rate (3-fold) in embryonic pancreas.
• This mitogenic effect was specific to embryonic beta cells; adult beta cells and embryonic alpha cells/adrenal chromaffin cells showed no significant changes.
• The [LeuA3]insulin and the double mutant did not alter beta-cell numbers compared to controls.

Conclusions:

• The [AspB10]ProIN/IN analog demonstrates a potent mitogenic effect on fetal beta-cell proliferation.
• The observed proliferation enhancement is specific to the embryonic beta-cell population.
• The precise molecular mechanisms underlying this [AspB10]ProIN/IN-mediated mitogenesis require further elucidation.